Research
Comparison of Canadian public medication insurance plans and the impact on out-of-pocket costs
David J.T. Campbell, Braden J. Manns, Lesley J.J. Soril and Fiona Clement
November 27, 2017 5 (4) E808-E813; DOI: https://doi.org/10.9778/cmajo.20170065
David J.T. Campbell
Departments of Medicine (Campbell, Manns) and Community Health Sciences (Manns, Soril, Clement) and O'Brien Institute for Public Health (Manns, Clement), Cumming School of Medicine, University of Calgary, Calgary, Alta.
MDPhDBraden J. Manns
Departments of Medicine (Campbell, Manns) and Community Health Sciences (Manns, Soril, Clement) and O'Brien Institute for Public Health (Manns, Clement), Cumming School of Medicine, University of Calgary, Calgary, Alta.
MScLesley J.J. Soril
Departments of Medicine (Campbell, Manns) and Community Health Sciences (Manns, Soril, Clement) and O'Brien Institute for Public Health (Manns, Clement), Cumming School of Medicine, University of Calgary, Calgary, Alta.
MScFiona Clement
Departments of Medicine (Campbell, Manns) and Community Health Sciences (Manns, Soril, Clement) and O'Brien Institute for Public Health (Manns, Clement), Cumming School of Medicine, University of Calgary, Calgary, Alta.
PhD
Submit a Response to This Article
Jump to comment:
No Responses have been published for this article.
In this issue
Article tools
Comparison of Canadian public medication insurance plans and the impact on out-of-pocket costs
David J.T. Campbell, Braden J. Manns, Lesley J.J. Soril, Fiona Clement
Dec 2017, 5 (4) E808-E813; DOI: 10.9778/cmajo.20170065
Related Articles
Cited By...
- Comparison of claims from high-drug cost beneficiaries in Ontario, Canada, and Australia: a cross-sectional analysis
- Projected impact of biosimilar substitution policies on drug use and costs in Ontario, Canada: a cross-sectional time series analysis
- The human right to essential medicines applies to Canadians
- Le droit de la personne aux medicaments essentiels sapplique aux Canadiens
- Characteristics of high-drug-cost beneficiaries of public drug plans in 9 Canadian provinces: a cross-sectional analysis
- Drug coverage in Canada: gaps and opportunities